• OPEN AN ACCOUNT
Indian Indices
Sensex
85,041.45 -367.25
( -0.43%)
Global Indices
Nasdaq
48,728.27 -23.90
(-0.05%)
Dow Jones
6,949.98 -3.07
(-0.04%)
Hang Seng
50,641.54 233.75
(0.46%)
Nikkei 225
9,870.68 -18.54
(-0.19%)
Forex
USD-INR
89.83 0.26
(0.29%)
EUR-INR
105.77 0.25
(0.24%)
GBP-INR
121.29 0.43
(0.36%)
JPY-INR
0.58 0.00
(0.43%)

EQUITY - MARKET SCREENER

Mercury Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
538964
INE947G01011
464.6533333
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
20
98.26
EPS(TTM)
Face Value()
Div & Yield %
40.95
10
0.43
 

Maruti Suzuki gains after reporting 26% YoY sales growth in November 2025
Dec 01,2025
The sales of domestic passenger vehicles stood at 1,70,971 units (up 20.99% YoY), while sales of light commercial vehicles came in at 3,622 units (up 23.79% YoY) during the period under review.

While the company's total domestic sales (PV+LCV+OEM) jumped 19.66% YoY to 1,82,964 units, total export sales increased by 60.85% YoY to 46,057 units sold in November 2025.

For the period from April- November of FY26, the company has registered total sales of 1,528,650 units, up 5.32% YoY.

Maruti Suzuki India is engaged in the manufacture, purchase, and sale of motor vehicles, components, and spare parts (automobiles).

The company reported a 7.9% increase in consolidated net profit to Rs 3,349 crore on a 12.8% jump in revenue from operations to Rs 40,138.70 crore in Q2 FY26 over Q2 FY25.